SPG
58
-3
AEP
56
-3
EXPD
39
-4
PNR
63
-2
DVA
70
-5
MU
44
-3
FCX
56
-9
MKC
35
-3
KMI
44
-7
HOG
30
4
NUE
39
-2
JWN
71
3
NEM
41
-5
NWS
77
-4
NFLX
62
-2
HBI
46
-6
DG
38
-6
HSIC
44
-4
PAYX
59
3
WM
82
6
SPG
58
-3
AEP
56
-3
EXPD
39
-4
PNR
63
-2
DVA
70
-5
MU
44
-3
FCX
56
-9
MKC
35
-3
KMI
44
-7
HOG
30
4
NUE
39
-2
JWN
71
3
NEM
41
-5
NWS
77
-4
NFLX
62
-2
HBI
46
-6
DG
38
-6
HSIC
44
-4
PAYX
59
3
WM
82
6
Financhill
Back

Sonnet BioTherapeutics Holdings Vs. CytomX Therapeutics Industry Stock Comparison

Sell
24

SONN
Sonnet BioTherapeutics Holdings

Last Price:
1.74
Seasonality Move:
-13.87%
Sell
20

CTMX
CytomX Therapeutics

Last Price:
1.89
Seasonality Move:
-12.9%
Sell
24
Sonnet BioTherapeutics Holdings (SONN) is a Sell

Is Sonnet BioTherapeutics Holdings a Buy, Sell or Hold?

  • The current Sonnet BioTherapeutics Holdings [SONN] share price is $1.74. The Score for SONN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • SONN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
CytomX Therapeutics (CTMX) is a Sell

Is CytomX Therapeutics a Buy, Sell or Hold?

  • The current CytomX Therapeutics [CTMX] share price is $1.88. The Score for CTMX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • CTMX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SONN Stock Price Chart

What is Sonnet BioTherapeutics Holdings's stock price today?

  • The Sonnet BioTherapeutics Holdings share price today is $1.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SONN is experiencing slight buying pressure.

CTMX Stock Price Chart

What is CytomX Therapeutics's stock price today?

  • The CytomX Therapeutics share price today is $1.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTMX is experiencing slight buying pressure.

SONN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 46.08 Sell
Chaikin Money Flow: 21261 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.73 - 1.85) Sell
Bollinger Bands (100): (1.51 - 1.97) Sell

CTMX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 42.53 Sell
Chaikin Money Flow: 202987 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.29 - 3.59) Sell
Bollinger Bands (100): (1.32 - 2.72) Sell

SONN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.78 Sell
20-day SMA: 1.8 Sell
50-day SMA: 1.88 Sell
200-day SMA: 2.36 Sell
8-day EMA: 1.76 Sell
20-day EMA: 1.79 Sell
50-day EMA: 1.82 Sell
200-day EMA: 5.43 Sell

CTMX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.92 Sell
20-day SMA: 2.63 Sell
50-day SMA: 2.26 Sell
200-day SMA: 1.69 Buy
8-day EMA: 2.06 Sell
20-day EMA: 2.31 Sell
50-day EMA: 2.27 Sell
200-day EMA: 1.9 Sell

Sonnet BioTherapeutics Holdings Earnings Growth & SONN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.01 per share, and a decrease next year of $0.35 per share.

CytomX Therapeutics Earnings Growth & CTMX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.41 per share.

Sonnet BioTherapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CytomX Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):